To the full analysis
Xylem stock: growth
XYLXylem reported $9.04B in revenue for fiscal 2025, up 5.5% on the prior year, up 13.1% a year on average over up to five years.
Daily figure as of 13 Nov 2026
Revenue (Annual rate)
7.5%
per year from 2009 to 2025, per share 5.6%
Earnings (Annual rate)
8.4%
per year from 2009 to 2025, per share 6.6%
Free cash flow (Annual rate)
7%
per year from 2009 to 2025, per share 5.2%
Growth per year by period
What reaches shareholders is growth per share: buybacks lift it, new shares dilute it.
| since 2020 | since 2015 | since 2009 | |
|---|---|---|---|
| Revenue | 13.1% | 9.5% | 7.5% |
| Revenue per share | 6.5% | 6.3% | 5.6% |
| Earnings | 30.4% | 10.9% | 8.4% |
| Earnings per share | 22.8% | 7.7% | 6.6% |
| Free cash flow | 7.3% | 10.1% | 7.0% |
| Free cash flow per share | 1.0% | 6.9% | 5.2% |
Fiscal years at a glance
How revenue and earnings grow
- Revenue
- Earnings
- Free cash flow
Figures as a table
| Year | Revenue | Earnings | Free cash flow |
|---|---|---|---|
| 2009 | $2.85B | $263M | $308M |
| 2010 | $3.2B | $329M | $301M |
| 2011 | $3.8B | $279M | $323M |
| 2012 | $3.79B | $297M | $284M |
| 2013 | $3.84B | $228M | $198M |
| 2014 | $3.92B | $337M | $297M |
| 2015 | $3.65B | $340M | $347M |
| 2016 | $3.77B | $260M | $373M |
| 2017 | $4.71B | $331M | $516M |
| 2018 | $5.21B | $549M | $349M |
| 2019 | $5.25B | $401M | $613M |
| 2020 | $4.88B | $254M | $641M |
| 2021 | $5.2B | $427M | $330M |
| 2022 | $5.52B | $355M | $388M |
| 2023 | $7.36B | $609M | $566M |
| 2024 | $8.56B | $890M | $942M |
| 2025 | $9.04B | $957M | $910M |
Revenue by region
Where Xylem Inc. generates its revenue.
- United States58%
- Europe20%
- Asia Pacific14%
- Other8%
“Other” combines smaller regions with revenue the company does not assign to a region.
Figures as a table
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | Share 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| United States | $1.57B | $2.16B | $2.42B | $2.55B | $2.3B | $2.28B | $2.57B | $3.96B | $4.86B | $5.21B | 57.7% |
| Europe | $1.2B | $1.34B | $1.45B | $1.38B | $1.41B | $1.41B | $1.41B | $1.66B | $1.75B | $1.84B | 20.4% |
| Asia Pacific | $518M | $611M | $660M | $659M | $618M | $1.07B | $1.07B | $1.18B | $1.27B | $1.22B | 13.5% |
| Other | $484M | $600M | $674M | $656M | $554M | $435M | $464M | $571M | $681M | $766M | 8.5% |
| Total revenue | $3.77B | $4.71B | $5.21B | $5.25B | $4.88B | $5.2B | $5.52B | $7.36B | $8.56B | $9.04B | 100% |
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Neutral, published since 7 Nov 2026 (in the score history since 31 Oct 2023)
- Valuation signal Fairly valued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.